Aspiringdocs.org. Reliable tools, information, and support you need to explore whether a career in medicine is right for you. 

CPIC Guidelines. ASCPT’s Board of Directors has voted to endorse Clinical Pharmacogenetic Implementation Consortium (CPIC)® guidelines.

Merck Manual Professional: Clinical Pharmacology. Online medical library for healthcare professionals. 

National Institute of General Medical Sciences. One of the National Institutes of Health supporting research that is the foundation for disease diagnosis, treatment and prevention. 

Pediatric Trials Network (PTN). The Pediatric Trials Network (PTN) is an alliance of clinical research sites from around the U.S. that are cooperating in the design and conduct of pediatric clinical trials to improve health care for the youngest patients. The PTN is sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, which established it in response to the Best Pharmaceuticals for Children Act.

Pharmacogenetics Research Network. A nationwide collaboration of scientists studying the effect of genes on people's responses to a wide variety of medicines. 

NIH Pharmacogenomics Research Network. This program is in collaboration with NIGMS, as well as other secondary institutions including NHGRI, NCI, NIAMS, NICHD, NIDA, NIMH, and OWHR. The program was designed to support multidisciplinary, collaborative research groups to study how genetic variation contributes to interindividual differences in responses to medications.

PharmGKB. The PharmGKB is a pharmacogenomics knowledge resource that encompasses clinical information including dosing guidelines and drug labels, potentially clinically actionable gene-drug associations and genotype-phenotype relationships

"Principles of Clinical Pharmacology" Course sponsored by the National Institutes of Health Clinical Center in Bethesda, Maryland. The course provides an introductory review of pharmacokinetics, drug metabolism and transport, pharmacogenetics, assessment of drug effects, drug therapy in special populations, and drug discovery and development. 

UCSF-FDA Transportal. The purpose of this database is to be a useful repository of information on transporters important in the drug discovery process as a part of the US Food and Drug Administration-led Critical Path Initiative. Information includes transporter expression, localization, substrates, inhibitors, and drug-drug interactions.

Disclosure Statement 

Although every reasonable effort is made to present current and accurate information for public use, ASCPT and its employees and agents do not make any guarantees of any kind about the content, accuracy, or timeliness of information on the ASCPT website. The use of information on ASCPT’s server and website is strictly voluntary and at the user’s sole risk. ASCPT disclaims all express warranties included in any materials, and further disclaims all implied warranties, including warranties of merchantability, fitness for a particular purpose, and non-infringement of proprietary rights. ASCPT shall not be liable for any damages of any kind. 

ASCPT does not endorse, nor is it affiliated with any third party entity, which may have provided a link to this website or, which you may link to from this web site. Any links to external web sites are provided as a courtesy. ASCPT does not control, monitor, or guarantee the information contained in any other entity web sites.